Differences in Type I Diabetes Mellitus of Young Adults with and without Thyroid Autoimmunity

Abstract

This work was intended to study if the coexistence of thyroid and Langerhans islets autoimmunity is associated with a different nature and course of diabetes in young adult diabetic patients. We followed the laboratory and clinical course of diabetes and the thyroid gland status of 47 young adults with Type I diabetes over a 9-year period starting from the onset of diabetes (ranging from 18 to 35 years of age). The patients were divided into subgroup I (with thyroid peroxidase and thyroglobulin antibodies, n = 13), subgroup II (thyroid peroxidase antibody only, n = 10), and subgroup III (without thyroid autoimmunity, n = 24). Out of the 22 females followed, 10 (46 %) and 5 (23 %) were in subgroups with thyroid autoimmunity (TA), I and II, respectively. On the contrary, out of the 25 men followed, 17 (68 %) were in group III. Within the 9 years, insulin secretion nearly ceased (C-peptide < 0.03 nmol/L) in all of the patients of subgroup I and 70 % of subgroup II, but only in 46 % of patients in subgroup III (I : II p < 0.01, I : III, p < 0.01, II : III, p < 0.05). The cumulative incidence of antiGAD > 1 U/mL (CIS, RIA) in subgroup I was higher (92 %) than in subgroups II (80 %) and III (53 %); I : III, p < 0.05. The cumulative incidence of tyrosine phosphatase antibodies (anti-IA2, BRAHMS, RIA) was insignificantly higher in subgroups I and II when compared with subgroup III (62 %, 60 %, and 42 %). The study of organ-specific and systemic autoantibodies showed their highest cumulative incidence in subgroup I, i.e., in patients with the most expressed manifestations of TA and the lowest one in subgroup III, i.e., diabetic patients without TA. Our results suggest that overall thyroid autoimmunity in young adult patients with Type I diabetes was associated not only with female gender, but also with more pronounced Langerhans islets autoimmunity and significantly faster cessation of endogenous insulin secretion; it was associated with therapeutical doses of insulin as well.

Thyroid autoimmunity - Langerhans islets autoimmunity - antiGAD - anti-IA2 - Type I diabetes of adults

References

• 1 De Block C, De Leeuw I. Thyroid autoimmunity does not influence the presence of chronic complications in type 1 diabetic patients. Abstract Book of the 5th European Congress of Endocrinology, Torino 2001,. 2001: P-289
• 2 Fernandez-Castaner M, Molina A, Lopez-Jimenez L, Gomez J M, Soler J. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity.  Diabetes Care. 1999;  22 377-381
• 3 Fernandez-Soto L, Gonzales A, Lobon J A, Lopez J A, Peterson C M, Escobar-Jiménez F. Thyroid peroxidase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women.  Diabetes Care. 1997;  20 1524-1528
• 4 Franzese A, Buono P, Mascolo M, Leo A L, Valerio G. Thyroid autoimmunity starting during the course of type 1 diabetes denotes a subgroup of children with more severe diabetes.  Diabetes Care. 2000;  23 1201-1202
• 5 Kordonouri O, Meyer K, Egerer K, Hartmann R, Scheffler S, Burmester G R, Kuckelkorn U, Danne T, Feist E. Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis.  J Pediatr Endocrionol Metab. 2004;  17 975-981
• 6 Matejková-Behanova M, Zamrazil V, Vondra K, Vrbikova J, Dryakova M, Hill M, Kucera P, Andel M. The influence of co-existing autoimmune thyroiditis on the clinical presentation of diabetes mellitus type 1 in elderly.  J Endocrinol Invest. 2001;  24 (Suppl to No. 6) 82 (Abstract)
• 7 Maugendre D, Sonnet E, Derrien C, Le Golff M C, Grais M C, Allannic H, Delamaire M. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.  Diabetes Metab. 1999;  25 28-33
• 8 McCanlies E, O'Leary L A, Foley T, Kramer M K, Burke J P, Libman A, Swan J S, Steenkiste A R, McCarthy B J, Trucco M, Dorman J S. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function.  J Clin Endocrinol Metab. 1998;  83 1548-1551
• 9 Mohn A, Di Michele S, Di Luzio R, Tumini S, Chiarelli F. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus.  Diabet Med. 2002;  19 70-73
• 10 Sterzl I, Vavrejnova V, Matucha P, Zamrazil V. Extrathyroid autoantibodies in autoimmune thyroiditis. Polyendocrine autoantibodies.  Thyroid Gland. 1999;  2 37-43
• 11 Vondra K, Vrbikova J, Sterzl I, Bilek R, Vondrova M, Zamrazil V. Thyroid autoantibodies and their clinical relevance in young adults with type 1 diabetes during the first 12 years after diabetes onset.  J Endocrinol Invest. 2004;  27 728-732
• 12 Yokota I, Matsuda J, Naito E, Ito M, Shima K, Kuroda Y. Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM.  Diabetes Care. 1998;  21 49-52